Delivery Order SPE2DR25D2206-SPE2DR26F9EJ9
- Not listed
- The Defense Logistics Agency awarded a $9,745.98 delivery order to AmerisourceBergen Drug Corp on December 16, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price delivery order with performance to be completed by January 8, 2026, at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract award represents a non-set-aside, competitively awarded transaction under the company's existing federal contract vehicle with the agency. This...
- The Defense Logistics Agency awarded a delivery order valued at $9,745.98 to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price delivery order with an ultimate completion date of December 31, 2025, issued with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a...
- The Defense Logistics Agency awarded a $12,330.68 delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by September 22, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 9, 2025, with completion expected by December 31, 2025. This competitively awarded, firm fixed-price delivery order requires performance at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Benlysta 200 mg/mL auto-injectors valued at $12,330.68 with a firm fixed price structure. This non-set-aside contract is scheduled for completion by September 12, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $6,497.32 firm fixed price delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Benlysta 200 mg/mL auto-injectors. This non-set-aside, competitively awarded contract is scheduled for completion by December 31, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for Benlysta 200 mg/ml auto-injector pharmaceutical supplies. This $6,165.34 firm fixed price delivery order is scheduled for completion by September 3, 2025, and represents a competitive award with no set-aside designation. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $6,497.32 delivery order to AmerisourceBergen Drug Corp for BENLYSTA 200 mg/ml auto-injector on November 13, 2025, with an ultimate completion date of December 5, 2025. This is a firm fixed price, non-set-aside contract to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX...
- The Defense Logistics Agency has awarded a delivery order valued at $9,745.98 to AmerisourceBergen Drug Corp for the supply of Benlysta 200 mg/ml auto-injector units. The contract, issued on December 22, 2025, with an ultimate completion date of January 14, 2026, represents a firm fixed-price delivery under a competitive, non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a delivery order valued at $3,248.66 to AmerisourceBergen Drug Corp for Benlysta 200 mg/ml auto-injector on December 5, 2025, with a completion date of December 29, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9EJ9Delivery Order
The Defense Logistics Agency awarded a $12,994.64 delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Benlysta 200 mg/ml auto-injector medication. This is a firm fixed-price delivery order with an ultimate completion date of December 26, 2025, and carries no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for medical procurement, particularly for military and veteran healthcare systems. The company's contract portfolio with the DLA demonstrates extensive capabilities in delivering brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Benlysta is a biologic treatment for systemic lupus erythematosus, and this delivery order fulfills the immediate pharmaceutical supply needs of Defense Health Agency and other government healthcare systems supported through the DLA's medical supply chain network.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.0k | 12/3/25 |